SM2+: Facing a New Trial · 034/049 · standard

Lycanroc GX JP

Japanese printing. No linked printing in the other language yet.

A$7

0.0%

Raw · Market ask from 1 asks · as of 6 Oct 2026 · last sale A$7

Raw market cap

—

Market cap uses PSA grades

Raw population

—

Not tracked yet

For sale in Australia

0

None listed yet

Raw value history

Not enough history yet.

Show the numbers
Daily Raw value, AUD
DateValue (A$)
7 Oct 20267

AUD · prices to 6 Oct 2026 · converted at the RBA daily rate · Sources: JustTCG market prices from recent sales (raw and graded, converted from USD), TCGTracker marketplace · Methodology

By grade

PSA grades drive market cap. BGS, CGC and SGC values are shown for comparison: the same card can sell for different amounts in each company’s slab.

Lycanroc GX value, population and market cap by grading company and grade
GradeValue (A$)PopulationMarket capLast sale30d median sold
Raw7——A$7A$7

For sale in Australia

All listings for this card

No copies listed yet. Get an alert when one is.

More from SM2+: Facing a New Trial

News

No articles mention this card yet.

Identifiers

card_id
332aeb08-68ed-4802-ba3c-72986e070ccc
Set code
jt-sm2-facing-a-new-trial
PSA spec
—
justtcg
1afe1fc3-67f5-5f19-8bec-a6a623242462:jp:standard